Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02239913 · ClinicalTrials.gov registry record · Phase 1
Topiramate-Phentermine Combinations for Cocaine Dependence
A Phase 1 study, sponsored by University of Kentucky.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
NCT02239913 is a Phase 1 study that has completed, run by University of Kentucky. The registered enrollment target is 38 participants.
The verdict
NCT02239913, a Phase 1 study, has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
Study Summary
This study will determine the influence of topiramate (Topamax®) and phentermine (Adipex®), alone and in combination, on the reinforcing, subjective and physiological effects of cocaine.
Interventions
- DRUG Placebo
- DRUG Topiramate
- DRUG Phentermine
- DRUG Cocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2014-09 |
| Est. Completion | 2019-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02239913
The ClinicalTrials.gov registry entry for NCT02239913 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kentucky, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02239913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02239913 about?
NCT02239913 is a clinical study titled "Topiramate-Phentermine Combinations for Cocaine Dependence". This study will determine the influence of topiramate (Topamax®) and phentermine (Adipex®), alone and in combination, on the reinforcing, subjective and physiological effects of cocaine.
What is the current status of trial NCT02239913?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2014-09. Estimated completion is 2019-09.
What interventions are being tested in trial NCT02239913?
The interventions under investigation include: Placebo (DRUG), Topiramate (DRUG), Phentermine (DRUG), Cocaine (DRUG).
Who is sponsoring clinical trial NCT02239913?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.